Current update on the protective effect of naringin in inflammatory lung diseases

• Gaurav Gupta,
• Waleed Hassan Almalki,
• Imran Kazmi,
• Neeraj Kumar Fuloria,
• Shivkanya Fuloria,
• Vetriselvan Subramaniyan,
• Mahendran Sekar,
• Sachin Kumar Singh,
• Dinesh Kumar Chellappan,
• Kamal Dua

Affiliations

Gaurav Gupta

ORCiD

School of Pharmacy, Suresh Gyan Vihar University, Jagatpura 302017, Mahal Road, Jaipur, India. E-mail: [email protected]

Waleed Hassan Almalki

ORCiD

Department of Pharmacology, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia

Imran Kazmi

ORCiD

Department of Biochemistry, Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia

Neeraj Kumar Fuloria

ORCiD

Faculty of Pharmacy, AIMST University, Bedong 08100, Kedah, Malaysia

Shivkanya Fuloria

ORCiD

Faculty of Pharmacy, AIMST University, Bedong 08100, Kedah, Malaysia

Vetriselvan Subramaniyan

ORCiD

Faculty of Medicine, Bioscience and Nursing, MAHSA University, Jalan SP 2, Bandar Saujana Putra, 42610 Jenjarom Selangor, Malaysia

Mahendran Sekar

ORCiD

Department of Pharmaceutical Chemistry, Faculty of Pharmacy and Health Sciences, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh 30450, Perak, Malaysia

Sachin Kumar Singh

ORCiD

School of Pharmaceutical Sciences, Lovely Professional University, Phagwara, Punjab, 144411, India; Faculty of Health, Australian Research Center in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, 2007, Australia

Dinesh Kumar Chellappan

ORCiD

Department of Life Sciences, School of Pharmacy, International Medical University, Kuala Lumpur, 57000, Malaysia

Kamal Dua

ORCiD

Discipline of Pharmacy, Graduate School of Health, University of Technology Sydney, NSW 2007, Australia; Faculty of Health, Australian Research Center in Complementary and Integrative Medicine, University of Technology Sydney, Ultimo, NSW, 2007, Australia